Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.938133
Abstract: Objectives: Osteoarthritis (OA) is a common disease that mainly manifests as inflammation and destruction of cartilage and subchondral bone. Recently, necroptosis has been reported to play an important role in the development of OA. Selumetinib… read more here.
Keywords: small molecule; selumetinib potential; cartilage; osteoarthritis ... See more keywords